Nicht aus der Schweiz? Besuchen Sie lehmanns.de
New Research on Alzheimer's Disease -

New Research on Alzheimer's Disease

Eileen M Welsh (Herausgeber)

Buch | Hardcover
264 Seiten
2006
Nova Science Publishers Inc (Verlag)
978-1-59454-939-7 (ISBN)
CHF 299,95 inkl. MwSt
Dementia is a brain disorder that affects a person's ability to carry out daily activities. The common form of dementia among older people is Alzheimer's Disease (AD). This book gathers research from scientists which offers information on understanding the causes and discovering the treatments for this disease.
Dementia is a brain disorder that seriously affects a person's ability to carry out daily activities. The most common form of dementia among older people is Alzheimer's Disease (AD), which involves the parts of the brain that control memory, thought and language. Age is the most important known risk factor for AD. The number of people with the disease doubles every 5 years beyond age 65. AD is a slow disease, starting with mild memory loss and ending with severe brain damage. The course the disease takes and how fast changes occur vary from person to person. On average, AD patients live from 8 to 10 years after they are diagnosed, though the disease can last for as many as 20 years. Current research is aimed at understanding why AD occurs and who is at greatest risk for developing it, improving the accuracy of diagnosis and ability to identify who is at risk, developing, discovering and testing new treatments for behavioural problems in patients with AD. This book gathers state-of-the-art research from leading scientists throughout the world which offers important information on understanding the underlying causes and discovering the most effective treatments for Alzheimer's Disease.

Preface; Insights on Alzheimer's Disease from the Intracerebral Injection and Infusion of Amyloid-ss; The Role of Phospholipase A2 in Alzheimer's Disease; Low Molecular Weight Glycosaminoglycans and Apoptosis: Potential Treatment of Neurodegenerative Disorders Including Alzheimer's Disease; Low Density Lipoprotein Receptor-related Protein 1 (LRP1)- one of the Hallmarks of Alzheimer's Disease and other Complex Degenerative Processes; The Role of Peroxisome Proliferator-Actuvated Receptors in Alheimer's Disease; Role of Sphingomyelin Cycle Signaling System in Alheimer's Disease; Ischemia-reperfusion Factors in Sporadic Alzheimer's Disease; Amyloid Beta (Ass) Peptides in Plasma as Biochemical Markers of Alzheimer's Disease and Mild Cognitive Impairment; Index.

Erscheint lt. Verlag 28.7.2006
Zusatzinfo Illustrations
Verlagsort New York
Sprache englisch
Maße 260 x 180 mm
Gewicht 820 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Geriatrie
Medizin / Pharmazie Medizinische Fachgebiete Neurologie
ISBN-10 1-59454-939-7 / 1594549397
ISBN-13 978-1-59454-939-7 / 9781594549397
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Gisela Mötzing; Susanna Schwarz

Buch | Softcover (2022)
Urban & Fischer in Elsevier (Verlag)
CHF 46,15
das gesamte Spektrum der Altersmedizin für Klinik und Praxis

von Jürgen M. Bauer; Clemens Becker; Michael Denkinger

Buch | Hardcover (2024)
Kohlhammer (Verlag)
CHF 259,95
Das Wichtigste für Ärztinnen und Ärzte aller Fachrichtungen

von Klaus Hager; Olaf Krause

Buch | Softcover (2021)
Urban & Fischer in Elsevier (Verlag)
CHF 51,80